Trials / Completed
CompletedNCT01597427
Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac Surgery
Intravenous Clonidine Does Not Reduce Pulmonary Artery Pressure in Patients Subjected to Cardiac
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Federal University of São Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the ability of clonidine to reduce the mean pulmonary artery pressure in patients with pulmonary hypertension subjected to cardiac surgery.
Detailed description
Prospective, clinical-interventionist, randomized, and double-blind study. Patients with group 2 pulmonary hypertension will be included and subjected to cardiac surgery with extracorporeal circulation. Mean pulmonary artery pressure and the doses of dobutamine and sodium nitroprusside will be assessed four times: before (T0) administration of 2 μg/kg of intravenous clonidine or a placebo, 30 minutes after the onset of treatment (T1), immediately after extracorporeal circulation (T2), and 10 minutes after the injection of protamine (T3).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clonidine | Administration of 2 μg/kg of intravenous clonidine |
| DRUG | Placebo | Injection of placebo solution. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-04-01
- Completion
- 2012-03-01
- First posted
- 2012-05-14
- Last updated
- 2012-05-14
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01597427. Inclusion in this directory is not an endorsement.